OTR3 SAS - Company Review
OTR3 SAS - Company ReviewSummary
OTR3 SAS (OTR3) is a biotechnology company that develops therapeutic agents. The company’s products comprise CACIPLIQ20 and CACICOL20. Its CACIPLIQ20 is a cutaneous cicatrization kit used to treat chronic skin wounds including arteritic and venous ulcers, diabetic foot and pressure ulcers. OTR3’s CACICOL20 is a single-dose eye drop for ocular cicatrization to treat chronic corneal lesions. The company develops therapeutic agents based on regenerating agents technology. It has developed a polymer mimetic of the heparan sulfates, which are capable of reconstructing the scaffolding around the cells and allows natural signals to place themselves in space. OTR3 is headquartered in Paris, France.
This comprehensive company report of OTR3 SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.